- 96829-59-3L-Leucine, N-formyl-,(1S,3Z,6Z)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]-3,6-dodecadien-1-ylester
- 968-29-6Benzenepropanamide,N-(4-nitrophenyl)-b-oxo-
- 96829-60-61,7-Ethenocycloprop[c]isobenzofuran,4-[(1R)-1,5-dimethyl-4-hexenyl]-1,1a,3,3a,4,5,6,7-octahydro-7-methyl-,(1R,1aR,3aR,4R,7R,7aR)- (9CI)
- 96-83-3Benzenepropanoic acid,3-amino-a-ethyl-2,4,6-triiodo-
- 96835-17-52H-Pyran-4-carboxylicacid, tetrahydro-, ethyl ester
- 96841-04-25-AMINO-4-CHLORO-3-METHYLISOTHIAZOLE
- 96846-67-21,1-Dimethyl-5-methyleneheptyl butyrate
- 96846-71-8Dipotassium 4,4-bis((4-methoxyphenyl)azo)stilbene-2,2-disulphonate
- 96847-55-1Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-phenyl-, (1R,2S)-
- 96849-38-6L-Isoleucinamide,L-histidyl-L-alanyl-L-a-aspartylglycyl-L-valyl-L-phenylalanyl-L-threonyl-L-seryl-L-a-aspartyl-L-tyrosyl-L-seryl-L-arginyl-L-leucyl-L-leucylglycyl-L-glutaminyl-L-isoleucyl-L-seryl-L-alanyl-L-lysyl-L-lysyl-L-tyrosyl-L-leucyl-L-a-glutamyl-L-seryl-L-leucyl- (9CI)
Hot Products
- 56-40-6Glycine
- 75-09-2Dichloromethane
- 1333-86-4Carbon Black
- 64-19-7Acetic acid glacial
- 120-51-4Benzyl benzoate
- 9004-32-4Carboxymethyl cellulose
- 7783-20-2Ammonium sulfate
- 123-31-9Hydroquinone
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Orlistat |
EINECS | 639-755-1 |
| CAS No. | 96829-58-2 | Density | 0.976 g/cm3 |
| PSA | 81.70000 | LogP | 7.90870 |
| Solubility | DMSO: 19 mg/mL in water | Melting Point |
<50 °C |
| Formula | C29H53NO5 | Boiling Point | 615.9 °C at 760 mmHg |
| Molecular Weight | 495.744 | Flash Point | 326.3 °C |
| Transport Information | N/A | Appearance | off-white solid |
| Safety | Risk Codes | N/A | |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
(-)-Tetrahydrolipstatin;Alli;N-Formyl-L-leucine, ester with (3S,4S)-3-hexyl-4-((2S)-2-hydroxytridecyl)-2-oxetanone;Orlistat [USAN:INN];Ro 18-0647/002;Orlipastatum [INN-Latin];L-Leucine, N-formyl-, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester, (2S-(2alpha(R*),3beta))-;[(2S)-1-[(2S,3S)-3-hexyl-4-oxo-oxetan-2-yl]tridecan-2-yl] 2-formamido-4-methyl-pentanoate;Tetrahydrolipstatin;Xenical;L-Leucine,N-formyl-,(1S)-1-[[(2S,3S)-3- hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester;Taizhou hikong chemical sell orlistat; |
Article Data | 51 |
Orlistat Chemical Properties
Molecular Structure:
Molecular Formula: C29H53NO5
Molecular Weight: 495.73
CAS NO: 96829-58-2
H bond acceptors: 6
H bond donors: 1
Freely Rotating Bonds: 23
Polar Surface Area: 72.91 Å2
Index of Refraction: 1.469
Molar Refractivity: 141.57 cm3
Molar Volume: 507.5 cm3
Surface Tension: 35.6 dyne/cm
Density: 0.976 g/cm3
Flash Point: 326.3 °C
Melting Point: <50 °C
Enthalpy of Vaporization: 91.36 kJ/mol
Boiling Point: 615.9 °C at 760 mmHg
Vapour Pressure: 4.23E-15 mmHg at 25°C
Storage temp: 2-8°C
Solubility: DMSO: 19 mg/mL
Appearance: Off-White Solid
IUPAC Name: [(2S)-1-[(2S,3S)-3-Hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate
Synonyms of Orlistat (CAS NO.96829-58-2): (-)-Tetrahydrolipstatin ; Alli ; L-Leucine, N-formyl-, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester, (2S-(2alpha(R*),3beta))- ; N-Formyl-L-leucine, ester with (3S,4S)-3-hexyl-4-((2S)-2-hydroxytridecyl)-2-oxetanone ; Orlipastat ; Orlipastatum ; Orlipastatum [INN-Latin] ; Ro 18-0647/002 ; Tetrahydrolipstatin ; UNII-95M8R751W8 ; Xenical ; L-Leucine, N-formyl-, (1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester
Product Categories of Orlistat (CAS NO.96829-58-2): Pharmaceutical Raw Materials;Miscellaneous
Biochemicals;API;Antiobesity Agent;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals
Orlistat Uses
Orlistat (CAS NO.96829-58-2) is a drug designed to treat obesity. It is mainly used for preventing the absorption of fats from the human diet, thereby reducing caloric intake. Besides, it is intended for use in conjunction with a physician-supervised reduced-calorie diet.
Orlistat Safety Profile
WGK Germany: 3
RTECS: OH3167600
Orlistat Specification
Side effects of Orlistat (CAS NO.96829-58-2): The primary side effects of the drug are gastrointestinal-related, and include steatorrhea (oily, loose stools with excessive flatus due to unabsorbed fats reaching the large intestine), fecal incontinence and frequent or urgent bowel movements.
What can I do for you?
Get Best Price
